Eusedex 1 mL Concentrated solution for intravenous infusion.
PDF Leaflet Revision Date: 16 May 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Sedation in ICU and during minor surgical procedures.
Dosage (summary)
Loading: 1.0 mcg/kg over 10 mins; Maintenance: 0.2-0.7 mcg/kg/hr.
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; crosses placenta; monitor breastfed infants for irritability.
Key Drug Interactions
- Anaesthetics
- Sedatives
- Opioids
Contraindications
- Hypersensitivity to dexmedetomidine
- Sepsis
- Unstable trauma
- Hypovolaemia
- Heart block
- Uncontrolled cardiac failure
- Imminent hepatic failure
Common side effects
- Hypotension
- Bradycardia
- Nausea
- Dry mouth
- Hypoxia
Counselling Points
- Do not drive or operate machinery for 24 hours post-surgery.
- Monitor for signs of hypotension and bradycardia.
- Fluid supplementation is necessary during infusion.
Serious warnings
- Continuous monitoring required
- Risk of bradycardia and sinus arrest
- Not for use in non-surgical ICU patients
Important Disclaimer
The Eusedex 1 mL Concentrated solution for intravenous infusion. professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
